Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


Helix Biopharma to Present L-DOS47 Lung Cancer Research Findings at the Fourth International Conference on Tumor Microenvironment in Florence, Italy

- Helix BioPharma Corp. (TSX: HBP /Frankfurt: WKN918864) AURORA, ON, March 5 /CNW/Dr. Heman Chao, Vice President of Researchat Helix BioPharma Corp., a developer of novel cancer therapeutics,will be presenting a scientific poster at the Fourth InternationalConference on Tumor Microenvironment, which runs from March 6th to10th in Florence, Italy. The conference, hosted by the...

Replidyne Phase II Pediatric Trial Meets Primary Objective

LOUISVILLE, Colo., March 06, 2007 /PRNewswire-FirstCall/ --Replidyne, Inc. announced today that it has completed its Phase IIclinical trial using faropenem medoxomil (faropenem) in pediatricpatients with acute otitis media (AOM), a common infection of themiddle ear. Initial analyses of the study results show that it metits primary objective to show that faropenem was effective ineradicatin...

DVT Awareness Survey Findings: Heart and Respiratory Patients

WASHINGTON, March 06, 2007 /PRNewswire/ -- Up to two millionAmericans are affected each year by DVT, with up to 600,000hospitalized. Its primary complication, pulmonary embolism (PE),claims up to 300,000 lives annually -- more than breast cancer andAIDS combined. People who suffer from cardiovascular disease may beat increased risk for DVT, because these factors also heighten thelikelihood...

Pozen Announces Positive Outcome for PA 325

Chapel Hill, N.C., March 6, 2007-Pozen Inc. (NASDAQ: POZN),today announced top-line results of its "Safer Aspirin" PA 325proof-of-concept study conducted during the fourth quarter of 2006.PA 325 is a patented formulation of 325mg of aspirin surrounded bya 20mg coating of an immediate release formulation of a proton pumpinhibitor. The PA 325, 28 day study, involved two groups of 40 subject...

Advanced Magnetics Announces Presentation of Ferumoxytol Data at the National Kidney Foundation 2007 Spring Clinical Meetings

CAMBRIDGE, Mass., March 06, 2007 /PRNewswire-FirstCall/ --Advanced Magnetics today announced that data from three completedPhase III multi- center clinical studies of ferumoxytol as anintravenous iron replacement therapeutic will be presented duringthe National Kidney Foundation (NKF) 2007 Spring Clinical Meetingstaking place April 10th through 14th in Orlando, Florida. Twoposters containi...

POZEN Announces Positive Outcome for PA 325 Proof of Concept Study

CHAPEL HILL, N.C.--(BUSINESS WIRE)--Mar 6, 2007 - POZEN Inc.(NASDAQ: POZN), today announced top-line results of its "SaferAspirin" PA 325 proof-of-concept study conducted during the fourthquarter of 2006. PA 325 is a patented formulation of 325mg ofaspirin surrounded by a 20mg coating of an immediate releaseformulation of a proton pump inhibitor. The PA 325, 28 day study, involved two group...

Nventa Announces Presentation of Positive HspE7 Data from NCI-Sponsored Clinical Trial in Cervical Dysplasia

- 78 Percent of Patients Showed Complete Response or Reduction ofLesion Size by More than Fifty Percent - SAN DIEGO, CA, March 05, 2007 /PRNewswire-FirstCall/ - NventaBiopharmaceuticals Corporation today announced the presentation ofpositive results from a clinical trial examining the safety andefficacy of pilot process HspE7, an investigational therapeuticvaccine for human papillomavirus (...

AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II Study with Novel Cystic Fibrosis Therapy

VIENNA, Austria and CHAPEL HILL, N.C., US, March 06, 2007/PRNewswire/ -- AOP Orphan Pharmaceuticals AG ("AOP Orphan") andLantibio, Inc. ("Lantibio") today announced positive final resultsfrom their placebo controlled, double-blinded Phase II clinicalstudy of Moli1901, an experimental compound to treat cysticfibrosis ("CF"). Moli1901 is being developed by AOP Orphan inEurope under a licensi...

Advanced Cell Technology's Ability to Rescue Vision in Blind Rats Noted in Scientific American

ALAMEDA, Calif.--(BUSINESS WIRE)--Mar 5, 2007 - Advanced CellTechnology, Inc.'s (OTCBB: ACTC) ability to rescue vision in blindrats was noted in Scientific American's March 2007 issue as thelead story of its News Scan section. The full text of the article,which notes Advanced Cell's ability to "coax embryonic stem cellsto turn into transplantable retinal pigment epithelial (RPE)tissue," is...

Accentia Biopharmaceuticals Scientific Presentations Demonstrate Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at the Annual Meeting of the American Academy of Allergy, Asthma, and Immunology

TAMPA, Fla.--(BUSINESS WIRE)--Mar 7, 2007 - AccentiaBiopharmaceuticals, Inc. (NASDAQ: ABPI), presented three posters atthe Annual Meeting of the American Academy of Allergy, Asthma, andImmunology from February 23 - 27, 2007 in San Diego, CA. Theposters discussed findings from a survey of 202 otolaryngologists(ENTs) and allergists in the U.S., U.K., France, and Germany on theburden of chroni...
[next]
(Date:12/9/2019)... ... ... WEDI , the nation’s leading nonprofit authority on the use of health IT ... U.S. Department of Health and Human Services (HHS), announced today the election of a ... the re-election of ten previous board members to serve two-year terms. , “The WEDI ...
(Date:12/9/2019)... ... 2019 , ... OCLI, a Spectrum Vision Partners (SVP) managed practice, has announced ... and Ophthalmology practice with experience spanning decades. As part of OCLI, Drs. Cary Silverman, ... location at 46 Eagle Rock Ave, East Hanover, NJ 07936. , Over ...
(Date:12/8/2019)... ... December 07, 2019 , ... Intelligent.com, a trusted ... 55 Best Master of Science in Nursing (MSN) Degree Programs for 2020. The ... universities in the nation. Each program is evaluated based on curriculum quality, graduation ...
(Date:12/6/2019)... ... December 06, 2019 , ... ... recognized for excellence in employee learning. The Omaha-based company has been named by ... the most successful employer-sponsored training and development programs worldwide. Rankings of the 125 ...
(Date:12/6/2019)... ... December 06, 2019 , ... In a ceremony where words ... Lake Community College’s (SLCC) Emergency Medical Technician (EMT) Program—Maria Mazzel Delgado, Jake ... AT&T Public Safety Hero Scholarship to support their first responder training. ...
Breaking Medicine News(10 mins):
... Jan. 31 Speaker Nancy Pelosi,issued the following statement ... in Medicare and Medicaid when he unveils his fiscal,2009 ... once again slash health care coverage,for seniors and low-income ... when the cost of health care and the number ...
... to premature ovarian failure, researchers report , , THURSDAY, Jan. ... a mechanism that prompts early menopause and might account ... a gene that,s known for suppressing tumor growth -- ... ripening too quickly. When researchers deleted the PTEN gene ...
... MedWaves, Inc. announces the receipt,of USFDA 510k clearance ... surgery use for the coagulation and,ablation of soft ... generator,and single patient use sterile devices. The clearance ... portfolio and indications for use through,additional USFDA submissions ...
... the highly contagious, fast-moving virus is again a public ... and Epidemiology (APIC) has six simple steps to protect ... most frequent cause of illness after the common cold. ... occur between 24 and 48 hours after exposure. Norovirus ...
... most hospitals already stocked with simple, inexpensive solution , , THURSDAY, ... (magnesium sulfate) given just before delivery to pregnant women at ... palsy among these newborns in half, U.S. researchers report. , ... United States. All the women were at high risk for ...
... may be one of the top killers in the country, but ... attending the annual congress of the Society for Critical Care Medicine ... the U.S. have high blood pressure, yet many of them dont ... number are not taking the medications they need to control it," ...
Cached Medicine News:
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 8.0 mm and length 5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard crankshaft-type 1/1 (mm), opening width 7.0 mm and length 5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Fenestrated large type 1/1 (mm), opening width 8.0 mm and length 10 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 10.0 mm and length 10 mm....
Medicine Products:
(Date:12/5/2019)... ... December 05, 2019 , ... ... has announced the Top 27 Respiratory Therapy Degree Programs for 2020. The comprehensive ... in the nation. Each program is evaluated based on curriculum quality, graduation rate, ...
(Date:12/4/2019)... ... December 04, 2019 , ... Tenex Health, Inc., a ... to treat chronic pain in soft and hard tissue, recently achieved a major ... , Dr. Bernard Morrey, Chief Medical Officer of Tenex Health, said, “Our ...
(Date:12/2/2019)... LOS ANGELES (PRWEB) , ... December 02, 2019 ... ... provider and owner of A Mission for Michael, an intensive mental health facility, ... Recovery Activists to oversee client relations, business development and national advocacy efforts. , ...
Breaking Medicine Technology:
... 2011 Reportlinker.com announces that a new ... catalogue: Orthopaedics: Market Prospects ... http://www.reportlinker.com/p0573671/Orthopaedics-Market-Prospects-GlobalCompetition .html#utm_source=prnewswire&utm_medium=pr&utm_campaign=General_Medicine_and_Specialty_Medicine ... projected to be 5% over the period ...
... DIEGO, July 19, 2011 CareFusion Corporation (NYSE: CFN ... release fourth quarter and fiscal 2011 results on Monday, Aug. 8 ... The company will host a webcast and conference call ... discuss the results for its fourth quarter and fiscal 2011, ended ...
Cached Medicine Technology: